Palvella Therapeutics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2019-11-12: Form 10-Q; Exhibit 10.3; Description Non-Qualified Stock Option Agreement by and between the Registrant and Hitto Kaufmann, Ph.D., dated as of August 30, 2019..
- 2019-11-12: Form 10-Q; Exhibit 10.2; Description Managing Director Services Agreement by and between Pieris Pharmaceuticals GmbH and Hitto Kaufmann, PhD., dated February 20, 2019..
- 2019-11-04: Form 8-K; Exhibit 10.3; Description Registration Rights Agreement, dated November 2, 2019, by and among the Company and the Investors named therein.
- 2019-11-04: Form 8-K; Exhibit 10.2; Description Form of Warrant to purchase Common Stock.
| Filed | Form | Exhibit | Description |
|---|
| 2019-11-12 | 10-Q | 10.3 | Non-Qualified Stock Option Agreement by and between the Registrant and Hitto Kaufmann, Ph.D., dated as of August 30, 2019. |
|---|
| 2019-11-12 | 10-Q | 10.2 | Managing Director Services Agreement by and between Pieris Pharmaceuticals GmbH and Hitto Kaufmann, PhD., dated February 20, 2019. |
|---|
| 2019-11-04 | 8-K | 10.3 | Registration Rights Agreement, dated November 2, 2019, by and among the Company and the Investors named therein |
|---|
| 2019-11-04 | 8-K | 10.2 | Form of Warrant to purchase Common Stock |
|---|
| 2019-11-04 | 8-K | 10.1 | Securities Purchase Agreement, dated November 2, 2019, by and among the Company and the Investors named therein |
|---|
| 2019-08-09 | 10-Q | 10.29.1 | Subtenant Recognition and Attornment Agreement, by and among Pieris Pharmaceuticals, Inc., 225 State Street, LLC, and Berenberg Capital Markets LLC, dated as of May 31, 2019 |
|---|
| 2019-08-09 | 10-Q | 10.2 | Pieris Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy. |
|---|
| 2019-08-09 | 10-Q | 10.1 | Open Market Sale Agreement, dated as of August 9, 2019, by and between Pieris Pharmaceuticals, Inc. and Jefferies LLC. |
|---|
| 2019-07-31 | 8-K | 10.1 | Pieris Pharmaceuticals, Inc. 2019 Employee, Director and Consultant Equity Incentive Plan. |
|---|
| 2019-03-18 | 10-K | 10.30 | Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermögen GmbH, dated October 24, 2018 |
|---|
| 2019-03-18 | 10-K | 10.27 | Non-Employee Director Compensation Policy, as amended |
|---|
| 2019-02-04 | 8-K | 10.1 | Exchange Agreement by and among Pieris Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS, L.P., dated as of January 30, 2019. |
|---|